Phosphoric Acid

Phosphoric Acid

SCHEMBL2834959

CCCCCCCCCCCCCOCCCCCCCCCCCCC.O=P(O)(O)O

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
LPAR3 Q9UBY5 11/20 0.64
LPAR2 Q9HBW0 6/20 0.64
LPAR1 Q92633 4/20 0.64
MEN1 O00255 1/20 0.60
THRB P10828 1/20 0.60
HTT P42858 1/20 0.60
KMT2A Q03164 1/20 0.60
MAPT P10636 1/20 0.60
LPAR5 Q9H1C0 1/20 0.56
CES2 O00748 2/20 0.56
TSHR P16473 2/20 0.52
CYP3A4 P08684 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL29448223 1.00 LPAR3 (0.64) LPAR3LPAR2LPAR1MEN1THRB
Phosphoric Acid SCHEMBL571233 1.00 LPAR3 (0.64) LPAR3LPAR2LPAR1MEN1THRB
Phosphoric Acid SCHEMBL28649671 1.00 LPAR3 (0.64) LPAR3LPAR2LPAR1MEN1THRB
Phosphoric Acid SCHEMBL4933641 1.00 LPAR3 (0.64) LPAR3LPAR2LPAR1MEN1THRB
Phosphoric Acid SCHEMBL2836099 1.00 LPAR3 (0.64) LPAR3LPAR2LPAR1MEN1THRB
Phosphoric Acid SCHEMBL30585176 1.00 LPAR3 (0.64) LPAR3LPAR2LPAR1MEN1THRB
Phosphoric Acid SCHEMBL350762 1.00 LPAR3 (0.64) LPAR3LPAR2LPAR1MEN1THRB
Phosphoric Acid SCHEMBL11362386 1.00 LPAR3 (0.64) LPAR3LPAR2LPAR1MEN1THRB
Phosphoric Acid SCHEMBL8707171 1.00 LPAR3 (0.64) LPAR3LPAR2LPAR1MEN1THRB
Phosphoric Acid SCHEMBL29977560 1.00 LPAR3 (0.64) LPAR3LPAR2LPAR1MEN1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250261634-A1 LIQUID HERBICIDAL COMPOSITIONS UPL LTD (IN) 2025-08-21 US claimed
CN-118639354-B Antibacterial spandex spinning oil and preparation method thereof 烟台锐泽化学品有限公司 2024-10-22 CN claimed
CN-118788369-A Preparation method of phosphorus-containing hydrofining catalyst 中国石油化工股份有限公司 2024-10-18 CN claimed
CN-118767975-A Preparation method of bulk phase hydrocracking catalyst 中国石油化工股份有限公司 2024-10-15 CN claimed
CN-118639354-A Antibacterial spandex spinning oil and preparation method thereof 烟台锐泽化学品有限公司 2024-09-13 CN claimed
CN-118421391-B Preparation method and application of water-based rolling liquid for rolling power battery aluminum foil 石家庄新泰特种油有限公司 2024-08-30 CN claimed
CN-118421391-A Preparation method and application of water-based rolling liquid for rolling power battery aluminum foil 石家庄新泰特种油有限公司 2024-08-02 CN claimed
CN-115999630-B Phosphorus-containing hydrocracking catalyst and preparation method and application thereof 中国石油化工股份有限公司 2024-07-05 CN claimed
CN-115999597-B Phosphorus-containing hydrofining catalyst and preparation method thereof 中国石油化工股份有限公司 2024-07-02 CN claimed
CN-117772243-A Preparation method of phosphorus-containing copper-zinc catalyst 中国石油化工股份有限公司 2024-03-29 CN claimed
US-11167257-B2 Surfactant compositions and use thereof as inverter of water-in-oil emulsion polymers ECOLAB USA INC. (US) 2021-11-09 US claimed
EP-3731958-A1 SURFACTANT COMPOSITIONS AND USES AS INVERTERS Ecolab USA, Inc. (US) 2020-11-04 EP claimed
WO-2020113218-A2 SURFACTANT COMPOSITIONS AND USE THEREOF ECOLAB USA INC. (US) 2020-06-04 WO claimed
US-20190201858-A1 SURFACTANT COMPOSITIONS AND USE THEREOF AS INVERTER OF WATER-IN-OIL EMULSION POLYMERS ECOLAB USA INC. 2019-07-04 US claimed
CN-102436164-B The intermediate transfer element of phosphate ester polyimide containing Xerox Corp. (US) Patent Dept. 020 Xerox Square 100 Clinton Avenue Rochester New (US) 2016-04-20 CN claimed
US-8299150-B2 Aromatic polycarbonate resin composition and molding thereof IDEMITSU KOSAN CO., LTD. (JP) 2012-10-30 US claimed
CN-102575200-A Auto-emulsifying cleaning systems and methods for use RHODIA OPERATIONS 2012-07-11 CN claimed
US-6730631-B1 PRODUCING PHTHALIC ANHYDRIDE; SURFACTANT SYSTEM Consortium für elektrochemische Industrie GmbH (DE) 2004-05-04 US claimed
CN-1130266-C Method of producing monolithic oxidation catalysts and their use in gas phase oxidation of carbohydrates ELECTROCHEMISHE IND GMBH INTER (DE) 2003-12-10 CN claimed
CN-1360520-A Method of producing monolithic oxidation catalysts and their use in gas phase oxidation of carbohydrates CONSORTIUM ELEKTROCHEM IND (DE) 2002-07-24 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11167257-B2 Surfactant compositions and use thereof as inverter of water-in-oil emulsion polymers DEGS1, IPMK, DDOST LPAR3 1718/4885LPAR2 1933/4885LPAR1 1497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.